Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 35.71% ano a ano.
Avaliação Justa
O PE mais recente da empresa é -11.46, em uma faixa percentil média de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 88.22M ações, uma redução de 10.14% em relação ao trimestre anterior.